Neuphoria Therapeutics Inc (NEUP)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Fiscal Year End Date: 06/30
(Values in U.S. thousands)
| 12-2025 | 09-2025 | 06-2025 | 03-2025 | 12-2024 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 22,250 | 13,728 | 14,289 | 17,045 | 4,345 |
| Receivables | 1,110 | 2 | 12 | 25 | 36 |
| TOTAL | $23,387 | $13,952 | $15,041 | $17,090 | $4,399 |
| Non-Current Assets | |||||
| PPE Net | N/A | 3 | 3 | 2 | 2 |
| Intangibles | 13,211 | 13,314 | 13,443 | 13,422 | 13,544 |
| Other Non-Current Assets | 0 | 75 | 103 | 200 | 224 |
| TOTAL | $13,211 | $13,392 | $13,549 | $13,623 | $13,770 |
| Total Assets | $36,598 | $27,344 | $28,590 | $30,713 | $18,168 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 521 | 1,371 | 1,154 | 745 | 1,531 |
| Accrued Expenses | 2,066 | 3,668 | 2,950 | 685 | 485 |
| TOTAL | $2,586 | $5,124 | $4,221 | $1,552 | $2,134 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 3,886 | 9,249 | 4,871 | 2,402 | 1,444 |
| TOTAL | $4,311 | $9,710 | $5,366 | $3,164 | $2,287 |
| Total Liabilities | $6,898 | $14,834 | $9,587 | $4,716 | $4,420 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 5,391 | 5,377 | 2,358 | 1,880 | 1,757 |
| Retained earnings | -186,389 | -188,253 | -178,347 | -169,463 | -180,725 |
| Other shareholders' equity | -2,225 | -2,796 | -2,845 | -3,913 | -3,717 |
| TOTAL | $29,701 | $12,510 | $19,003 | $25,997 | $13,748 |
| Total Liabilities And Equity | $36,598 | $27,344 | $28,590 | $30,713 | $18,168 |